Wells Fargo’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Wells Fargo’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-74,040	Closed	-$3.12M	–	7727
2023 Q2	$3.12M	Sell	74,040 -97,146	-57%	-$3.93M	﹤0.01%	2533
2023 Q1	$6.1M	Buy	171,186 +34,882	+26%	+$1.27M	﹤0.01%	1971
2022 Q4	$5M	Sell	136,304 -57,603	-30%	-$2.28M	﹤0.01%	2081
2022 Q3	$9.14M	Sell	193,907 -68,363	-26%	-$4.42M	﹤0.01%	1582
2022 Q2	$18.8M	Sell	262,270 -102,482	-28%	-$7.49M	0.01%	1163
2022 Q1	$29.5M	Sell	364,752 -32,593	-8%	-$2.76M	0.01%	1064
2021 Q4	$40.8M	Sell	397,345 -38,170	-9%	-$3.67M	0.01%	872
2021 Q3	$38.1M	Buy	435,515 +5,381	+1%	+$487K	0.01%	1224
2021 Q2	$38.5M	Buy	430,134 +45,714	+12%	+$3.86M	0.01%	1235
2021 Q1	$29.2M	Buy	384,420 +45,671	+13%	+$3.44M	0.01%	1381
2020 Q4	$23.1M	Sell	338,749 -11,915	-3%	-$743K	0.01%	1457
2020 Q3	$18.6M	Buy	350,664 +31,282	+10%	+$1.86M	0.01%	1459
2020 Q2	$18.6M	Sell	319,382 -33,133	-9%	-$1.78M	0.01%	1418
2020 Q1	$13.9M	Sell	352,515 -5,069	-1%	-$296K	﹤0.01%	1462
2019 Q4	$21.3M	Sell	357,584 -11,368	-3%	-$611K	0.01%	1419
2019 Q3	$19.6M	Buy	368,952 +7,890	+2%	+$405K	0.01%	1451
2019 Q2	$18.4M	Buy	361,062 +73,406	+26%	+$3.42M	0.01%	1513
2019 Q1	$14.9M	Sell	287,656 -312,889	-52%	-$15.2M	﹤0.01%	1662
2018 Q4	$23.6M	Buy	600,545 +341,671	+132%	+$15.9M	0.01%	1278
2018 Q3	$13.3M	Buy	258,874 +40,366	+18%	+$1.98M	﹤0.01%	1840
2018 Q2	$10.2M	Sell	218,508 -77,596	-26%	-$3.21M	﹤0.01%	2053
2018 Q1	$10.5M	Buy	296,104 +14,048	+5%	+$550K	﹤0.01%	1966
2017 Q4	$12.3M	Sell	282,056 -456,639	-62%	-$21.3M	﹤0.01%	1850
2017 Q3	$38.6M	Buy	738,695 +46,697	+7%	+$2.6M	0.01%	1027
2017 Q2	$40.5M	Sell	691,998 -12,946	-2%	-$673K	0.01%	972
2017 Q1	$32.3M	Sell	704,944 -109,917	-13%	-$5.47M	0.01%	1098
2016 Q4	$42.9M	Buy	814,861 +21,573	+3%	+$1.04M	0.02%	917
2016 Q3	$35.4M	Buy	793,288 +86,037	+12%	+$3.73M	0.01%	936
2016 Q2	$27M	Sell	707,251 -66,577	-9%	-$2.93M	0.01%	1110
2016 Q1	$31.9M	Buy	773,828 +82,406	+12%	+$3.4M	0.01%	1006
2015 Q4	$33.5M	Buy	691,422 +454,829	+192%	+$20.2M	0.01%	981
2015 Q3	$9.46M	Buy	236,593 +23,930	+11%	+$1.05M	﹤0.01%	1845
2015 Q2	$8.53M	Sell	212,663 -4,985	-2%	-$172K	﹤0.01%	2032
2015 Q1	$7.12M	Sell	217,648 -11,304	-5%	-$312K	﹤0.01%	2139
2014 Q4	$5.88M	Buy	+228,952	New	+$5.45M	﹤0.01%	2225

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's SYNH Position: Q3 2023 in Review

Wells Fargo sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 74,040 shares — an estimated $3.12M sold.

Wells Fargo first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $42.9M in Q4 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Wells Fargo reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Wells Fargo sold 74,040 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.12M.
Wells Fargo first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Wells Fargo's Syneos Health, Inc. Class A Common Stock position peaked at $42.9M in Q4 2016.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.